NPAS3 rs11845867: What Your Genotype Means
The rs11845867 variant is a single nucleotide polymorphism located within the NPAS3 gene. It has been identified in genome-wide association studies as being linked to self-reported allergy.
What each genotype means
Baseline allergy risk
This genotype represents the most common form of this variant in many populations. Research indicates this specific genetic marker is associated with self-reported allergy, though the evidence remains limited and does not confirm a direct cause. This result should not be used to diagnose or predict the development of any specific allergic condition.
This is the most frequent genotype observed for this variant across most global populations.
Increased allergy risk association
Carrying one copy of the G allele has been linked in genome-wide association studies to a higher likelihood of self-reported allergy. Because the evidence for this association is limited, this finding should be interpreted as a statistical observation rather than a clinical diagnosis. Please consult with a healthcare provider regarding any concerns about allergic symptoms.
This heterozygous genotype is common, appearing in a significant portion of the population globally.
Elevated allergy risk association
Individuals with this genotype carry two copies of the G allele, which has been statistically associated with self-reported allergy in large-scale studies. The link between this NPAS3 variant and allergy is considered limited, meaning it is one of many factors that may influence individual health. This information is for educational purposes and does not constitute medical advice.
This genotype is less common than the C/C or C/G combinations, reflecting the global minor allele frequency of approximately 29%.
Understanding the Variant
The variant rs11845867 is a single nucleotide polymorphism (SNP) located on chromosome 14. In the context of human genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific marker is situated within the NPAS3 gene, which stands for neuronal PAS domain protein 3. Researchers track these variants to understand how subtle differences in our genetic code might correlate with various physical traits or health conditions. While the presence of a specific allele at this location is statistically associated with certain traits, it is important to remember that most human traits are complex and influenced by a combination of many genetic factors, environmental exposures, and lifestyle choices. Genetic associations identified through large-scale studies provide a starting point for scientific inquiry rather than a definitive prediction of an individual's health outcomes.
The Role of the NPAS3 Gene
The NPAS3 gene encodes a protein that functions as a transcription factor, which is a type of protein that helps control the activity of other genes. Specifically, the NPAS3 protein is localized to the cell nucleus and is known to play a significant role in neurogenesis, the process by which new neurons are formed in the brain. Because of its involvement in brain development, variations in the NPAS3 gene have been extensively studied in the context of neuropsychiatric conditions, such as schizophrenia and cognitive disability. While its primary recognized function relates to the nervous system, the gene's expression and regulatory roles are broad. The link between this gene and allergy-related traits is an area of ongoing research, as scientists work to determine how a gene primarily associated with brain development might also influence immune system responses or allergic sensitivity.
Research Evidence and Associations
The association between rs11845867 and self-reported allergy was identified through genome-wide association studies (GWAS). These studies scan the genomes of large populations to find statistical correlations between specific genetic variants and observed traits. The evidence for this particular association is considered limited. While the initial findings suggested a link, such associations often require replication across diverse cohorts to confirm their robustness and biological relevance. It is common in genetic research for initial signals to appear in large meta-analyses, but the actual effect size of any single variant on a complex trait like allergy is typically very small. Consequently, this variant should be viewed as a piece of a much larger, incomplete puzzle regarding the genetic architecture of allergic responses, rather than a primary driver of the condition.
Population Frequency
The Global Minor Allele Frequency (GMAF) for the rs11845867 variant is approximately 0.2916. This frequency indicates that the variant is relatively common across the populations studied in large-scale genomic databases. Because it is a common variant, it is found in a significant portion of the general population, which is typical for markers identified in GWAS that contribute to common, complex traits. Frequency can vary significantly depending on ancestral background, and researchers often look at these differences to understand the evolutionary history of specific alleles. However, the presence of a common allele does not inherently imply a positive or negative health impact; it simply reflects the natural genetic diversity present within human populations. Understanding these frequencies helps scientists contextualize the prevalence of specific genetic markers when conducting further clinical or functional research.
Interpreting Your Genetic Information
Information regarding genetic variants like rs11845867 is intended for educational purposes and should not be used for medical diagnosis or to guide personal health decisions. Because the evidence linking this variant to allergy is limited, it does not provide a reliable basis for predicting whether an individual will develop allergies or how they might respond to treatment. If you have concerns about allergies or other health conditions, it is essential to consult with a qualified healthcare professional, such as an allergist or primary care physician. They can provide a comprehensive evaluation based on your medical history, physical symptoms, and clinical testing. Never make changes to your medication or health regimen based on genetic data without first discussing it with your clinician or pharmacist, as they are best equipped to interpret your health needs in a clinical context.
How common is this variant?
The GMAF for rs11845867 is 0.2916, indicating that the variant is relatively common across global populations.
Frequently asked questions
Does having the rs11845867 variant mean I have allergies?
No. This variant is only associated with self-reported allergy in statistical studies and is not a diagnostic test for any allergic condition.
Can I use this information to choose allergy medication?
No. You should never use genetic information to guide medication choices. Always discuss your treatment options and dosing with your clinician or pharmacist.
Is the NPAS3 gene only involved in brain function?
While NPAS3 is primarily known for its role in neurogenesis and brain development, research into its broader biological functions and potential links to other systems is ongoing.
Why is the evidence for this variant considered limited?
Evidence is considered limited when an association has been identified in a study but has not been consistently replicated or when the biological mechanism remains unclear.
Sources & further reading
Educational information only, last refreshed 9/20/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs11845867?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29